IndraLab
Statements
Anthra[1,9-cd]pyrazol-6(2H)-one inhibits JUN. 47 / 59
|
1
39
7
reach
"To clarify the signaling pathways underlying the BDNF expression changes due to Kir4.1 knockdown, astrocytes were pretreated with U0126 [a non competitive inhibitor of mitogen activated protein kinase (MEK) 1/2, 10 muM], SB202190 (an inhibitor of p38 MAPK, 10 muM), or SP600125 [an inhibitor of Jun amino-terminal kinase (JNK), 10 muM] for 30 min before the transfection with Kir4.1 siRNA or a negative control."
reach
"In the present study, we demonstrate that an anthrapyrazole SP600125, a reversible ATP-competitive inhibitor of JNK inhibits proliferation of human HMC-1 showed constitutive activation of JNK and c-Jun, and the inhibitory effect of SP600125 on cell proliferation was associated with cell cycle arrest at the G1 phase and apoptosis accompanied by the cleavage of caspase-3 and PARP."
reach
"Our Western blot results showed that repeated intrathecal injections of SP600125 significantly reduced the up-regulation of p-JNK and p-c-Jun in the spinal cord (Figure 6(b) and (c)), and immunofluorescence results further showed that p-JNK and p-c-Jun co-localization in both the microglia and astrocytes also decreased (Figure 7(a) and (b), Supplementary Figure 3(a) and (b))."